It is known that Cetuximab inhibits oral squamous cell carcinoma invasion and metastasis directly via degradation of epidermal growth factor receptor [21] and indirectly via inhibition of neo-angiogenesis [22]. The gene discussed is EGFR; the disease is oral cavity squamous cell carcinoma.